Affinia Therapeutics Secures $40 Million Series C to Power the Next Evolution in Gene Therapy

October 13, 2025

byFenoms Start-Up Research

Affinia Therapeutics, a pioneering biotechnology company advancing genetic medicine, has raised $40 million in a Series C funding round to...